In our cohort, 67 CH patients (61.5%) were identified to harbor DUOX2 variants, revealing a higher DUOX2 gene mutation rate, consistent with the findings of scholars in other regions of China, Korea, and Japan (34–37). Here, DUOX2 is linked to cyclic hematopoiesis.